Table 3 The susceptibilities of ESBL-screen positive Escherichia coli and Klebsiella pneumoniae strains isolated from HA and CA IAIs
| Â | Escherichia coli, ESBL+ | Klebsiella pneumoniae, ESBL+ | ||
|---|---|---|---|---|
HA% | CA% | HA% | CA% | |
Amikacin | 91.46 | 89.47 | 86.17 | 80.25 |
Piperacillin Tazobactam | 85.73 | 88.72 | 67.37 | 66.67 |
Ampicillin Sulbactam | 4.70 | 5.76 | 3.19 | 2.47 |
Imipenem | 97.84 | 96.74 | 84.40 | 80.25 |
Ertapenem | 92.02 | 91.98 | 77.66 | 71.61 |
Cefoxitin | 65.63 | 67.42 | 59.58 | 45.68 |
Ceftazidime | 33.80 | 37.09 | 36.17 | 25.93 |
Cefepime | 4.60 | 4.76 | 8.51 | 4.94 |
Ceftriaxone | 0.75 | 0.75 | 1.77 | 0.00 |
Cefotaxime | 0.47 | 0.00 | 1.06 | 1.23 |
Levofloxacin | 19.91 | 22.56 | 50.00 | 49.38 |
Ciprofloxacin | 17.09 | 18.04 | 36.17 | 33.33 |